Investigational combo therapy shows benefit for TP53 mutant MDS and AML patients
Myelodysplastic Syndromes (MDS) and acute myeloid leukaemia (AML) are rare haematologic malignancies of the bone…
Browsing: hypomethylating agents
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Mutant gene-targeted immunotherapy approach developed
- Genomic Data Commons provides unprecedented cancer data resource
- Researchers watch anti-cancer drug release from DNA nanostructures in real time
- Lab profiles histone mutational landscape of human cancers
- Unburdening China of cancer: trend analysis to assist prevention measures
- Single cell sequencing opens new avenues for eradicating leukaemia at its source
- Lung cancer cells have differential signalling responses to KRAS inhibitor treatment
- The enemy within: Understanding the mechanisms of r-chop resistance in b-cell lymphoma
